ENTITY
WuXi AppTec

WuXi AppTec (2359 HK)

347
Analysis
Health CareChina
WuXi AppTec Co., Ltd. manufactures medical products. The Company produces biological agents, antibodies, biological diagnostic reagents, and other products. WuXi AppTec also provides biological analysis, technical study, and other services.
more
Refresh
17 Jun 2019 07:16

Hansoh Pharma (翰森制药) Post-IPO Trading Update: Fairly Valued

Hansoh Pharma's IPO was priced at the high end and started trading last Friday. In our earlier note, we argued that the company should trade at...

Logo
549 Views
Share
12 Jun 2019 00:42

Jinxin Fertility Group IPO: 4Q Update Is Good but Is It Sustainable?

Jinxin Fertility Co Ltd (1951 HK) is a leading assisted reproductive service (ARS) provider in China and the US. Its network of ARS medical...

Logo
858 Views
Share
11 Jun 2019 17:58

Jinxin Fertility (锦欣生殖) IPO - Worth a Look Given the Sector, Existing Shareholders and Cornerstone

Jinxin Fertility Co Ltd (1659778D CH) plans to raise up to US$390m in its Hong Kong IPO. Ke Yan, CFA, FRM has covered most details of the company...

Logo
847 Views
Share
09 Jun 2019 17:57

Jinxin Fertility Group IPO Preview: Baby Boom or Bust?

Jinxin Fertility Co Ltd (1659778D CH) is a leading assisted reproductive service (ARS) provider in China and the US. Its network of ARS medical...

Logo
923 Views
Share
30 May 2019 12:12

Frontage Holdings (方达控股) Post-IPO Trading Update: Strong Demand and Volume but Fairly Valued

Frontage Holdings IPO attracted strong demand and was priced at the high end of the IPO pricing. In our previous insight, we have discussed that...

Logo
611 Views
Share
x